Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

Recruiting now

Conditions studied: Gynecologic Cancer, Radiotherapy Side Effect, Radiotherapy; Complications, Survivorship, Progression, Disease, Progression, Clinical

In brief

This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.

Key facts

Study ID

NCT06306170

Run by

IRCCS San Raffaele

People needed

1000

Starts

2024-02-15

Expected to finish

2029-02-15

Last updated by the study team

2025-04-22

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• gynecologic cancer patients
• >18 years old
• treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT)

You may not qualify if…

• other tumors
• > 90 years old

Where it is running

• San Raffaele Scientific Institute — Milan, MI, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.